Zopapogene imadenovecPAPZIMEOSTMRecurrent respiratory papillomatosis (RRP)NIHNCT04724980
…obstruction and transformation into malignant cancer can occur. Zopapogene imadenovec (PAPZIMEOSTM) , a novel HPV-Targeted Immuno-Activator, is the f…
Entity family
Named medicines, compounds, vaccines, and pharmacological agents. Examples include metformin, semaglutide, antibiotics.
This drug is selected. Its supporting articles are shown below.
…obstruction and transformation into malignant cancer can occur. Zopapogene imadenovec (PAPZIMEOSTM) , a novel HPV-Targeted Immuno-Activator, is the f…
…ic prostate cancer and targeting prostate acid phosphatase; and zopapogene imadenovec, approved in 2025 for recurrent respiratory papillomatosis, a r…